Financial reports
NT 10-K
Notice of late annual filing
14 Feb 18
NT 10-Q
Notice of late quarterly filing
14 Feb 18
10-Q
2018 Q2
Quarterly report
28 Dec 17
NT 10-Q
Notice of late quarterly filing
21 Dec 17
10-Q
2018 Q0
Quarterly report
11 Aug 17
10-Q
2017 Q3
Quarterly report
14 Jun 17
NT 10-Q
Notice of late quarterly filing
17 Mar 17
10-Q
2017 Q1
Quarterly report
14 Dec 16
Current reports
8-K
Departure of Directors or Certain Officers
16 Jan 18
8-K/A
Changes in Control of Registrant
21 Dec 17
8-K/A
Completion of Acquisition or Disposition of Assets
21 Dec 17
8-K/A
Financial Statements and Exhibits
21 Dec 17
8-K/A
Changes in Control of Registrant
21 Dec 17
8-K
Departure of Directors or Certain Officers
20 Nov 17
8-K
Termination of a Material Definitive Agreement
15 Jun 17
8-K/A
Health Advance Inc. Announces the Closing of the Acquisition of Hantian Labs
21 Apr 17
8-K
Health Advance Acquires Licensing Rights to Patent Pending Product Formulations Containing Cannabis, Kava, & Kratom Extracts
7 Mar 17
8-K
Health Advance Inc. Announces the Closing of the Acquisition of Hantian Labs
26 Jan 17
Registration and prospectus
253G1
Information omitted from offering circular
22 Apr 22
1-A/A
Offering $5M in Equity
11 Feb 22
1-A
Offering $5M in Equity
3 Jan 22
15-15D
Suspension of duty to report
20 May 21
S-1/A
IPO registration (amended)
17 Jan 12
S-1/A
IPO registration (amended)
3 Jan 12
S-1/A
IPO registration (amended)
9 Dec 11
S-1
IPO registration
30 Sep 11
Proxies
No filings
Other
QUALIF
Notice of qualification
19 Apr 22
CORRESP
Correspondence with SEC
14 Apr 22
CORRESP
Correspondence with SEC
11 Feb 22
UPLOAD
Letter from SEC
10 Jan 22
UPLOAD
Letter from SEC
14 Apr 15
CORRESP
Correspondence with SEC
7 Apr 15
UPLOAD
Letter from SEC
2 Apr 15
CORRESP
Correspondence with SEC
20 Mar 15
UPLOAD
Letter from SEC
12 Mar 15
EFFECT
Notice of effectiveness
26 Jan 12